Fluphenazine Hydrochloride Oral Solution USP (Concentrate)

2.1 Classification of the substance or mixture

This product is a mixture and is a pharmaceutical product. It is considered non- Hazardous according to the OSHA Hazard Communication Standard 2012 (29 CFR 1910.1200). Chemical family: Mixture

Hazard statements

Product is not considered hazardous when used as prescribed.

Additional information

Short term: Increased mortality in elderly patients with dementia-related psychosis. Fluphenazine HCl Elixir is not approved for the treatment of dementia-related psychosis. Long term: The possibility of liver damage, pigmentary retinopathy, lenticular and corneal deposits, and development of irreversible dyskinesia should be remembered when patients ae on prolonged therapy. Known Clinical Effects: The side effects most frequently reported are extrapyramidal symptoms. EU Indication of danger: Not classified. 00 Emergency overview Seek medical attention in case of accidental exposure or overdose. The product is generally safe when used as prescribed. Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the

Precautionary statements

potential risk. The precautionary statements and warnings included may not apply in all cases. Your General advice: needs may vary depending upon the potential of exposure in your workplace. See medical attention in case of accidental exposure or overdose. Eyes: Avoid contact with eyes. Skin Contact: Avoid skin contact. Inhalation: Not intended for inhalation. Ingestion: Generally safe at recommended doses. In case of overdose, seek medical attention immediately.

Storage

There are no special storage conditions for safety. For product integrity, store under conditions specified on the label.

Disposal

Dispose of in accordance with applicable laws and regulations.